Detomidine

DB11556InvestigationalVet approvedSmall molecule

Detomidine is an α2-adrenergic agonist that is used as a horse sedative. Normally, it is administered in the salt form, detomidine hydrochloride. This drug is prescribed by veterinarians and is... Currently, it is only approved by the FDA for use in horses but has been studied for use in other large animals.

Chemical structure of Detomidine
Mechanism
Curator reviewed
Primary indication
Used as a large animal sedative, primarily in horses.Curator reviewed
Formula / weight
C12H14N2 · 186.253 g/mol (avg)

Resolves to

Compound
UNII7N8K34P2XHCAS76631-46-4ChEMBLCHEMBL2110829KEGGD07795
Clinical / RWD
RxNorm22672
Structure
InChIKeyRHDJRPPFURBGLQ-UHFFFAOYSA-NSMILESCC1=C(C)C(CC2=CN=CN2)=CC=C1
Targets
Q9Y2I1NISCH

What you can answer from here — as of September 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,151Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Detomidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In